» Articles » PMID: 29288342

Empirical Wavelet Transform Based Features for Classification of Parkinson's Disease Severity

Overview
Journal J Med Syst
Date 2017 Dec 31
PMID 29288342
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a type of progressive neurodegenerative disorder that has affected a large part of the population till now. Several symptoms of PD include tremor, rigidity, slowness of movements and vocal impairments. In order to develop an effective diagnostic system, a number of algorithms were proposed mainly to distinguish healthy individuals from the ones with PD. However, most of the previous works were conducted based on a binary classification, with the early PD stage and the advanced ones being treated equally. Therefore, in this work, we propose a multiclass classification with three classes of PD severity level (mild, moderate, severe) and healthy control. The focus is to detect and classify PD using signals from wearable motion and audio sensors based on both empirical wavelet transform (EWT) and empirical wavelet packet transform (EWPT) respectively. The EWT/EWPT was applied to decompose both speech and motion data signals up to five levels. Next, several features are extracted after obtaining the instantaneous amplitudes and frequencies from the coefficients of the decomposed signals by applying the Hilbert transform. The performance of the algorithm was analysed using three classifiers - K-nearest neighbour (KNN), probabilistic neural network (PNN) and extreme learning machine (ELM). Experimental results demonstrated that our proposed approach had the ability to differentiate PD from non-PD subjects, including their severity level - with classification accuracies of more than 90% using EWT/EWPT-ELM based on signals from motion and audio sensors respectively. Additionally, classification accuracy of more than 95% was achieved when EWT/EWPT-ELM is applied to signals from integration of both signal's information.

Citing Articles

Subclinical tremor differentiation using long short-term memory networks.

Nanayakkara G, Chan P Phys Eng Sci Med. 2025; .

PMID: 39992543 DOI: 10.1007/s13246-025-01526-0.


The Role of Deep Learning and Gait Analysis in Parkinson's Disease: A Systematic Review.

Franco A, Russo M, Amboni M, Ponsiglione A, Di Filippo F, Romano M Sensors (Basel). 2024; 24(18).

PMID: 39338702 PMC: 11435660. DOI: 10.3390/s24185957.


Gait classification for early detection and severity rating of Parkinson's disease based on hybrid signal processing and machine learning methods.

Wang Q, Zeng W, Dai X Cogn Neurodyn. 2024; 18(1):109-132.

PMID: 38406205 PMC: 10881932. DOI: 10.1007/s11571-022-09925-9.


The advantages of artificial intelligence-based gait assessment in detecting, predicting, and managing Parkinson's disease.

Wu P, Cao B, Liang Z, Wu M Front Aging Neurosci. 2023; 15:1191378.

PMID: 37502426 PMC: 10368956. DOI: 10.3389/fnagi.2023.1191378.


Applied Machine Learning Techniques to Diagnose Voice-Affecting Conditions and Disorders: Systematic Literature Review.

Idrisoglu A, Dallora A, Anderberg P, Berglund J J Med Internet Res. 2023; 25:e46105.

PMID: 37467031 PMC: 10398366. DOI: 10.2196/46105.


References
1.
Meigal A, Rissanen S, Tarvainen M, Karjalainen P, Iudina-Vassel I, Airaksinen O . Novel parameters of surface EMG in patients with Parkinson's disease and healthy young and old controls. J Electromyogr Kinesiol. 2008; 19(3):e206-13. DOI: 10.1016/j.jelekin.2008.02.008. View

2.
Little M, McSharry P, Hunter E, Spielman J, Ramig L . Suitability of dysphonia measurements for telemonitoring of Parkinson's disease. IEEE Trans Biomed Eng. 2011; 56(4):1015. PMC: 3051371. DOI: 10.1109/TBME.2008.2005954. View

3.
Nutt J, Bloem B, Giladi N, Hallett M, Horak F, Nieuwboer A . Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011; 10(8):734-44. PMC: 7293393. DOI: 10.1016/S1474-4422(11)70143-0. View

4.
Tanner C, Goldman S . Epidemiology of Parkinson's disease. Neurol Clin. 1996; 14(2):317-35. PMC: 7173037. View

5.
. Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. Arch Neurol. 2001; 58(10):1660-8. DOI: 10.1001/archneur.58.10.1660. View